Manufacturer record
Aan Life science Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Aan Life science Private Limited (Gujarat) were declared Not of Standard Quality in June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PDB108A, Amoxycillin Oral Suspension IP (exp Oct 2026). FDL, Vadodara (state lab) found it not of standard quality: Content of Amoxycillin. Listed in the June 2026 alert.
Records by type
11 records linked to Aan Life science Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin Oral Suspension IP | Batch PDB108AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB110AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB121AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB117AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB098AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB099AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB119AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB111AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB114AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB105AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | Batch PDB107AMfg Nov 2024 · Exp Oct 2026 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.